Metabolic changes in hemorrhagic shock.
D000273:Adipose Tissue / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005943:Gluconeogenesis; D000860:Hypoxia / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D010643:Phenoxybenzamine / Q000627:therapeutic use; D051381:Rats; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000378:metabolism*
D000317:Adrenergic alpha-Antagonists; D005230:Fatty Acids, Nonesterified; D010643:Phenoxybenzamine